🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The majority of patients (pts) with breast cancer have hormone receptor pos...
Status
Active Not Recruiting
Location
University of Miami
Start Date
2023-06-12
Trial ID
NCT05826964
Phase 2, open-label study of nab-sirolimus in patients with recurrent high ...
Status
Completed
Location
St. Joseph Heritage Healthcare
Start Date
2018-08-01
Trial ID
NCT03463265
RATIONALE: Everolimus may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2009-07
Trial ID
NCT00935792
Treatments Being Tested
The purpose of the study is to determine the effect of conversion from calc...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT00273871
Treatments Being Tested
The significance of this clinical trial lies in its potential to increase t...
Status
Completed
Location
Northwestern University
Start Date
2013-03
Trial ID
NCT02062944
Treatments Being Tested
RATIONALE: Temsirolimus may stop the growth of tumor cells by blocking some...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2010-06
Trial ID
NCT01155258
Treatments Being Tested
The investigators are proposing a prospective, randomized, double-blind, pl...
Status
Active Not Recruiting
Location
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
Start Date
2023-06-01
Trial ID
NCT05836025
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
This is a prospective, multi-center, open-label, phase Ib/ II study (two pa...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2012-01-30
Trial ID
NCT01495247
Treatments Being Tested
Investigating the safety and the activity of Rapamycin, administered before...
Status
Completed
Location
Maastricht Radiation Oncology
Start Date
2006-09
Trial ID
NCT00409994
Treatments Being Tested